HomeNewsWorldUS Treasury to distribute $4.8 billion in pandemic funds to tribal governments

US Treasury to distribute $4.8 billion in pandemic funds to tribal governments

The US Treasury Department will begin distributing $4.8 billion in pandemic-relief funds to Native American tribal governments in all U.S. states on Tuesday, the Treasury and Interior Departments said in a joint statement.

May 06, 2020 / 07:41 IST
Story continues below Advertisement

The US Treasury Department will begin distributing $4.8 billion in pandemic-relief funds to Native American tribal governments in all U.S. states on Tuesday, the Treasury and Interior Departments said in a joint statement.

Payments would begin Tuesday to help the tribes respond to the novel coronavirus outbreak based on population data in U.S. Census figures, the statement said, while payments based on employment and expenditure data would be made at a later date.

Story continues below Advertisement

Amounts calculated for Alaska Native Claims Settlement Act regional and village corporations, for-profit businesses that serve tribal villages in Alaska, would be held back until pending litigation relating to their eligibility was resolved, they said.

The decision frees up about 60% of the $8 billion in funds earmarked for Native tribes in the CARES Act, after delays caused by a legal dispute among the nation's native populations over who is entitled to the aid.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show